In 2018, the estimated incidence of prostate cancer was high, with Japan accounting for 6% (78,400 people) of the total...
Oncology
Another gene therapy product has been added to the FDA-approved list: SKYSONA, a one-time gene therapy aimed to treat early,...
A new hope is looming for Myelofibrosis patients who experienced a suboptimal response to ruxolitinib and those who were JAK...
Tisagenlecleucel, sold under the brand name Kymriah was the first gene therapy approved by the FDA on 30 August 2017....
On August 11, 2022, the FDA gave the green light for accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu) to treat adult...
During the last three months, the FDA approved several molecules and indications. In May, the following indications were approved: Fam-trastuzumab...
In February 2022, the Food and Drug Administration (FDA) approved nivolumab with platinum-doublet chemotherapy for adult patients with resectable non-small...
In February 2022, the Food and Drug Administration (FDA) approved ciltacabtagene autoleucel for Janssen Biotech for the treatment of adult...
Several indications and molecules were approved in December by FDA including the following: Abatacept for the prophylaxis of acute graft...
Emirates Oncology Society (EOS) and Ipsen joined forces to raise awareness of Neuroendocrine Tumors (NET), a rare type of cancer....
